Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Baxter
Accenture
Queensland Health
Colorcon
Merck
Johnson and Johnson
Express Scripts
QuintilesIMS
Chinese Patent Office

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,957,982

« Back to Dashboard

Summary for Patent: 3,957,982
Title: Method for contraception by the application of combination-type sequential preparations
Abstract:Method of contraception in which an estrogen and a progestagen are orally administered daily for 21 days, the first 4-6 days at a low contraceptively effective daily dose, the next 4-6 days at a daily estrogen dose 1-2 times and a daily progestrogen dose 1-1.5 times that of the first 4-6 days, and for the next 9-11 days at a daily estrogen dose from that of the first 4-6 days to that of the next 4-6 days and a daily progestogen dose higher than either prior daily dose, up to 3 times that of the initial dose, followed by 7 days without hormone administration.
Inventor(s): Lachnit-Fixson; Ursula (Berlin, DT), Pitchford; Alan G. (High Hurstwood, near Uckfield, EN)
Assignee: Schering Aktiengesellschaft (Berlin & Bergkamen, DT)
Application Number:05/535,575
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition; Dosage form;

Drugs Protected by US Patent 3,957,982

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 3,957,982

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
2365103Dec 21, 1973

International Patents Family Members for US Patent 3,957,982

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 7670874 ➤ Sign Up
Belgium 823689 ➤ Sign Up
Canada 1029303 ➤ Sign Up
Cyprus 1065 ➤ Sign Up
Germany 2365103 ➤ Sign Up
Denmark 155308 ➤ Sign Up
Denmark 667674 ➤ Sign Up
United Kingdom 1490099 ➤ Sign Up
Hong Kong 47080 ➤ Sign Up
Kenya 3059 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Cipla
Boehringer Ingelheim
Dow
Cerilliant
Covington
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot